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Abstract 
Smoking is a major contributor to the disparity in life expectancy between those with and without a 
mental health condition. Previous work has found associations between individual conditions such 
as depression and current smoking, cigarette consumption and dependence, but did not compare a 
range of specific mental disorders. Using data from the nationally-representative Adult Psychiatric 
Morbidity Survey, we characterised trends in smoking prevalence in the general population in Great 
Britain and among those with and without mental health conditions for the period 1993–2014. We 
tested associations across different common mental health conditions (including depression, phobia, 
generalised anxiety and mixed anxiety and depression), in addition to personality conditions, and 
heaviness of smoking, desire to quit, perceived difficulty of remaining abstinent and successful 
cessation within the previous 12 months. Smoking prevalence among those without any mental 
health condition decreased from 29.3% in 1993 to 19.6% in 2014. Prevalence was higher among 
those with a condition but fell from 44.6% to 34.1%. Having a mental health condition was 
associated with current smoking, heavy smoking, difficulty remaining abstinent, desire to quit and 
perceived difficulty remaining abstinent. The same was found for all conditions individually but the 
strength and significance of the associations varied. Having any common mental health condition 
was associated with lower odds of smoking cessation—but not after adjustment for heavy smoking. 
We found no significant associations between individual conditions and cessation outcomes, 
however. In summary, smoking prevalence among people with common mental health conditions 
remained around 50% higher than among those without despite their higher desire to quit. 
Adequately addressing higher dependence could support cessation and contribute to narrowing 
health disparities. 
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Highlights 
 
 First population-level study of smoking, quitting and mental health within the UK. 
 From 1993 to 2014, smoking prevalence fell in those with and without a condition. 
 Prevalence remained >50% higher among those with a mental health condition. 
 Those with conditions were more likely to smoke but had higher desire to quit. 
 Their lower odds of cessation diminished after adjustment for heavy smoking. 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Introduction 
There exist significant inequalities in health and life expectancy between individuals with mental 
health conditions and the general population (Chang et al., 2011; Thornicroft, 2013; Chesney, 
Goodwin & Fazel, 2014) which have been estimated at up to 12.0 years for women and 15.9 years 
for men (Lawrence, Hancock & Kisley, 2013). The difference in smoking prevalence between these 
groups is a major contributor to these persistent inequalities which can account for up to two thirds 
of the disparity in life expectancy (Tam, Warner & Meza, 2016). 
Previous evidence has shown that individuals with various types of mental health conditions are 
more likely to be smokers, more likely to be heavy smokers, and more likely to be highly dependent 
on cigarettes (Anda et al., 1990; Brown et al., 2000; Lasser et al., 2000; de Leon & Diaz, 2002; de 
Leon & Diaz, 2005; Morris et al., 2006; Hagman et al., 2008; Lawrence, Mitrou & Zubrick, 2009; 
Bowden et al., 2011; Royal College of Physicians & Royal College of Psychiatrists, 2013; Glasheen et 
al., 2014; Szatkowski & McNeill, 2015; Matcham et al., 2016; Lipari & Van Horn, 2017). Studies have 
found either no association (Prochaska et al., 2011; Matcham et al., 2016) or even a positive 
association (Anzai, Young-Wolff & Prochaska, 2015) between mental health conditions and desire to 
quit among smokers. Negative associations have also been found between having mental health 
conditions and odds of successful smoking cessation (Glassman et al., 1990; Anda et al., 1990; Lasser 
et al., 2000; de Leon & Diaz, 2005; Hagman et al., 2008; McClave et al., 2010; Glasheen et al., 2014). 
Although together these studies investigated various conditions, including depression, schizophrenia 
and anxiety, and their relationship with smoking-related outcomes, most only considered a single 
condition. The lack of comparable evidence on the associations between different specific conditions 
and their associations with smoking-related behaviours represents an important research gap and a 
missed opportunity to inform whether individuals with different conditions may face different 
barriers to successful cessation. Specifically, although there are differences in smoking prevalence 
between individuals with different conditions (Royal College of Physicians & Royal College of 
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Psychiatrists, 2013), to our knowledge no previous work has compared differences in other smoking-
related behaviours such as cessation. 
The objectives of this paper were to characterise the population-level trends in smoking prevalence 
among adults with and without a common mental health condition in Great Britain using a 
nationally-representative data sample, and analyse associations between specific conditions and 
outcomes including smoking status, heavy smoking and quitting behaviours at the individual level in 
2000 to elucidate the explanatory factors underlying the population-level trends. 
 
Materials and methods 
Data were obtained from the Adult Psychiatric Morbidity Survey (APMS), a representative survey of 
psychiatric morbidity among adults in private households in Great Britain administered by the Office 
for National Statistics (ONS) on behalf of the Department of Health, the Scottish Executive and the 
National Assembly for Wales (Meltzer et al, 1995). Four waves are currently available (1993, 2000, 
2007 and 2014) and sample sizes per wave range from 7,403–10,108. Smokers were defined as 
respondents who replied “yes” to the question “do you smoke cigarettes at all nowadays?” Ex-
smokers were defined as those who had reported ever trying a cigarette and were not currently 
smoking as per the pre-2016 ONS definition1 (ONS, 2017). The 2000 wave of APMS included 
variables pertaining to respondents’ smoking behaviour including quantity smoked and cessation.  
Respondents were categorised as having a mental health condition if they met the criteria for any 
common mental health condition (MHC) on the revised Clinical Interview Schedule (CIS-R) within the 
last week. These included depression, phobia, generalised anxiety disorder (GAD), panic disorder, 
obsessive-compulsive disorder (OCD) and mixed anxiety and depressive disorder. Mixed anxiety and 
depression is a ‘catch all’ category encompassing individuals with a score of ≥12 on the CIS-R who 
did not meet criteria for any of the other categories for neurotic conditions (Lewis et al., 1992). Panic 
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disorder and OCD were not tested separately as they comprised <3% of the sample with a MHC. The 
analyses used data from respondents aged 16–64 years as individuals outside this range were 
excluded from the 1993 wave. All analyses were performed in Stata 15 and applied cross-sectional 
survey weights. 
We estimated weighted proportions of smokers, ex-smokers and never-smokers among the 
population of Great Britain in each available wave of APMS, and then among those with and without 
a MHC. The proportion of smokers in each wave with a MHC was also estimated. 
We performed logistic regression analyses to test the associations between a respondent meeting 
the criteria for any MHC, depression, phobia, GAD, OCD or mixed anxiety and depression) compared 
with those who did not, and six different outcomes using data from the 2000 wave of APMS only2. 
Outcomes included (i) current smoking status, (ii) heavy smoking (≥20 cigarettes/weekday), (iii) 
dependence defined as a moderate or high Heaviness of Smoking Index (HSI) score (≥3) (Heatherton 
et al., 1989; Borland et al., 2010), (iv) desire to quit3, (v) perceived difficulty of remaining abstinent 
for one day4, and (vi) successful smoking cessation within the previous 12-month period5. 
Models were fitted for each CIS-R diagnostic category and outcome. Model 1 tested the unadjusted 
associations between CIS-R categories and each outcome. Models were then adjusted for socio-
demographic variables including gender, current age, ethnicity, partnership status, housing tenure, 
occupational position, level of education and age when the respondent first started smoking (if 
applicable) (Model 2). Models for desire to quit, difficulty remaining abstinent and 12-month 
smoking cessation were then further adjusted for heavy smoking6 (<20 or ≥20 cigarettes/weekday) 
currently or before successful cessation as appropriate (Model 3). The same procedures were used 
to test associations between personality conditions and smoking-related outcomes (see 
Supplementary Note). 
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Results 
Smoking prevalence in the general population in Great Britain decreased from 31.8% in 1993 to 
22.3% in 2014, and from 29.3% to 19.6% for those without a MHC, as evidenced by the non-
overlapping 95% CIs. Prevalence remained over 50% higher among those with a MHC, but fell from 
44.6% to 34.1% in the same period (Figure 1). The proportion of never-smokers in the general 
population exceeded that of current smokers by 2007 and ex-smokers by 2014. The proportion of 
smokers who had a MHC increased over the period studied from 22.3% (95% CI: 20.9–23.9) in 1993 
to 24.3% (95% CI: 22.5–26.1) in 2000, 24.5% (95% CI: 22.2–26.8) in 2007, and 28.8% (95% CI: 25.9–
31.7) in 2014. Although the proportion of ex-smokers in the general population remained constant 
or even declined over the study period, the proportion of ex-smokers as a proportion of ever-
smokers increased over time (increasing from 41.7% to 49.4% among those with a MHC and from 
57.1% to 66.2% among those without a MHC from 1993 to 2014). 
Of the 7,306 respondents in the 2000 wave with data on smoking status and MHCs, 2,360 (32.3%) 
were current smokers and 1,371 (18.8%) had any MHC7. The adjusted odds of current smoking 
(Model 2 OR: 1.79, 95% CI: 1.56–2.07, p<0.001), heavy smoking, moderate or high dependence and 
difficulty remaining abstinent were significantly higher among respondents with any MHC than those 
without (Table 1). Those with any MHC were more likely to report a desire to quit smoking even 
after adjustment for heavy smoking. Although odds of successful smoking cessation were 
significantly lower in this group (Model 2), the association was no longer significant after adjustment 
for heavy smoking (Model 3 OR: 0.82, 95% CI: 0.55–1.22, p=0.317). 
We also found statistically significant relationships between each of the four individual conditions 
tested and current smoking and moderate or high dependence; although the association of the 
latter with phobia was attenuated in the adjusted model. Only mixed anxiety and depression was 
found to have a significant relationship with heavy smoking after adjustment. GAD was significantly 
associated with both desire to quit and perceived difficulty remaining abstinent in the adjusted 
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model while depression was also associated with the latter. No individual condition was significantly 
associated with 12-month cessation outcomes. Results for the associations between personality 
conditions and smoking-related outcomes are shown in the Supplementary Note. 
 
Discussion 
We found a consistent and significant decline in smoking prevalence from 1993 to 2014 regardless of 
presence of MHCs. Promisingly, smoking prevalence decreased by around ten percentage points 
among those both with and without MHCs. Smoking prevalence among those with a MHC remained 
notably higher, however, with little indication of convergence. Estimates of smoking prevalence 
among people with mental health conditions using APMS 2014 data were comparable with those 
from other sources (Royal College of Physicians & Royal College of Psychiatrists, 2013). For example, 
Health Survey for England data estimated a smoking prevalence of 37.4% (95% CI: 31.9–43.1) among 
people reporting a longstanding mental health condition in 2010. People with MHCs in Great Britain 
had higher odds of smoking, heavy smoking, dependence, having desire to quit and perceiving 
abstinence as difficult while having lower odds of successful cessation (but not after adjusting for 
heavy smoking). Certain personality conditions were associated with higher odds of smoking, 
cigarette dependence and perceived difficultly remaining abstinent, but also greater desire to quit.  
Smoking prevalence among the population aged 16–64 is a function of individuals entering the 
smoking population on the one hand through initiation, relapse and younger smokers turning 16, 
and exiting on the other through smoking cessation, death and smokers ageing and falling out of the 
included age range (West & Brown, 2015). This suggests that while increasing rates of smoking 
cessation among those both with and without a MHC contributed somewhat to the decline in 
smoking prevalence in the population aged 16–64, the most important reason for the overall decline 
was decreasing smoking initiation and replacement of older smokers as evidenced by the rising 
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proportion of never-smokers (Hiscock et al., 2012). The higher smoking prevalence among those 
with a MHC is influenced both by lower rates of smoking cessation and higher rates of initiation 
given the lower proportion of both never-smokers and ex-smokers in this group. 
Encouragingly, and in agreement with previous findings (Siru, Hulse & Tait, 2009), we found that 
smokers with MHCs (and certain personality conditions) are just as or more likely to be motivated to 
quit than those without. Except for individuals with phobia, smokers with MHCs were less likely to 
successfully quit, however. The negative association between having any MHC and successful 
smoking cessation in the previous 12-month period was attenuated after adjustment for heavy 
smoking. This was not found for individual MHCs; none of which were significantly associated with 
lower odds of cessation in any the unadjusted or adjusted models. Taken together, despite their 
higher level of dependence and lower confidence in being able to remain abstinent, and after 
accounting for number of cigarettes smoked per day, these findings provide evidence against the 
common misconceptions among healthcare practitioners that people with mental health problems 
are less motivated and less likely to quit successfully (Sheals et al., 2016). 
Limitations of the study included the fact that only individuals in private households were 
interviewed, thus excluding certain groups which typically have a higher prevalence of MHCs and 
smoking such as those who are homeless or residing in institutions such as prisons or long-term 
mental health facilities (Jochelson & Majrowski, 2006). Due to data limitations, the study’s definition 
of ex-smokers may have overestimated the size of this group as it may have included individuals who 
had only smoked just one cigarette previously (ONS, 2017). Our population-level estimates of the 
proportion of ex-smokers may not be comparable with other studies. The statistical analysis of 
associations between mental health conditions and smoking and cessation outcomes was limited to 
data from the 2000 wave. The small number of respondents with particular MHCs (e.g. phobia)7 may 
have limited our ability to detect statistically significant associations with the outcomes tested.  
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To our knowledge, aside from one study which found that individuals who self-reported having 
mental health conditions had a higher smoking prevalence, higher cigarette consumption and similar 
desire to quit compared with those not reporting a condition (Szatkowski & McNeill, 2015), this 
study is the first to investigate smoking and cessation behaviour by presence of MHCs and 
personality conditions at the population level within the UK. Strengths of our study, which covered a 
period of 21 years, included its large sample size, representativeness of the population in Great 
Britain, and availability of data on specific MHCs assessed using validated and standardised clinical 
criteria. Although no specific condition had a significantly stronger association with any of the 
outcome measures employed, the study also addresses an important research gap by investigating 
the associations between specific MHCs and smoking-related behaviours. 
Although smoking prevalence has continued to decline in Britain, prevalence among vulnerable 
groups such as those with comorbid MHCs remains relatively high. Further progress in reducing 
smoking and its associated health harms is dependent on addressing specific challenges faced by 
these groups, such as higher nicotine dependence and perceived difficulty of remaining abstinent 
from cigarettes, to promote successful cessation and reduce initiation. Although several cost-
effective pharmacological and non-pharmacological interventions suitable for individuals with MHCs 
exist (Anthenelli et al., 2012; Peckham et al., 2017), access remains an issue (Szatkowski & McNeill, 
2013). Further work could address differences in access to treatment, help-seeking and quitting 
behaviours compared to the general population to inform both population-level policies and the 
design of tailored cessation interventions. In particular, future studies could consider whether 
specific nicotine delivery devices, pharmacotherapies or other quit aids may be particularly effective 
for facilitating cessation among individuals with different mental health conditions (or personality 
conditions), and whether assumptions of health care professionals (for example, around their desire 
to quit) may pose additional barriers to providing effective support. Our findings underscore the 
need to address excess smoking prevalence among people with MHCs, and the continuing 
importance of interventions such as improving identification of smokers in vulnerable groups within 
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primary and psychiatric settings, strengthening referral systems, increasing availability of 
pharmacotherapy and counselling, provision of advice for carers, hospital smoking bans and very 
brief advice to accelerate decline in smoking prevalence and bring about convergence with the 
general population (Lawn & Pols, 2005; NICE, 2013; Royal College of Physicians & Royal College of 
Psychiatrists, 2013; Britton, 2015; Royal College of Physicians, 2018). Unless disparities in smoking 
prevalence between those with and without a MHC are addressed, smoking will continue to 
contribute to health inequalities between these two groups. 
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Table 1. Odds of current smoking, heavy smoking, dependence (moderate or high HSI score), desire to quit and successful smoking cessation by 
presence of common mental health conditions among individuals aged 16–64 years in the Adult Psychiatric Morbidity Survey (2000) 
 
i. Current smoking (all respondents, n=7,003) 
Model 
Any MHC
1
 Depressive episode Phobia Generalised anxiety disorder Mixed anxiety/depression 
OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p 
Model 1 (unadjusted) 2.04 (1.78–2.33) <0.001 2.69 (2.01–3.61) <0.001 2.52 (1.77–3.60) <0.001 1.92 (1.53–2.40) <0.001 1.69 (1.41–2.02) <0.001 
Model 2
2
 1.79 (1.56–2.07) <0.001 2.03 (1.50–2.76) <0.001 1.76 (1.20–2.59) 0.004 1.65 (1.30–2.10) <0.001 1.63 (1.36–1.97) <0.001 
ii. Heavy smoking (current smokers, n=2,253) 
Model Any MHC Depressive episode Phobia Generalised anxiety disorder Mixed anxiety/depression 
OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p 
Model 1 (unadjusted) 1.48 (1.19–1.83) <0.001 1.48 (0.97–2.25) 0.067 1.73 (1.05–2.84) 0.031 1.41 (1.00–1.98) 0.052 1.36 (1.02–1.82) 0.035 
Model 2
2
 1.38 (1.09–1.75) 0.008 1.30 (0.85–1.97) 0.226 1.29 (0.76–2.19) 0.341 1.12 (0.78–1.61) 0.537 1.37 (1.00–1.87) 0.050 
iii. Dependence (moderate or high HSI score) (current smokers, n=2,249) 
Model Any MHC Depressive episode Phobia Generalised anxiety disorder Mixed anxiety/depression 
OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p 
Model 1 (unadjusted) 2.05 (1.66–2.53) <0.001 2.09 (1.39–3.15) <0.001 2.08 (1.26–3.42) 0.004 2.78 (1.97–3.90) <0.001 1.55 (1.18–2.05) 0.002 
Model 2
2
 1.86 (1.48–2.33) <0.001 1.76 (1.16–2.67) 0.008 1.48 (0.87–2.53) 0.152 2.23 (1.54–3.24) <0.001 1.50 (1.12–2.01) 0.007 
iv. Desire to quit (current smokers, n=2,240) 
Model 
Any MHC Depressive episode Phobia Generalised anxiety disorder Mixed anxiety/depression 
OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p 
Model 1 (unadjusted) 1.44 (1.13–1.83) 0.003 1.09 (0.69–1.72) 0.710 1.15 (0.68–1.95) 0.597 1.57 (1.03–2.39) 0.035 1.39 (1.01–1.92) 0.043 
Model 2
2
 1.43 (1.12–1.83) 0.004 1.08 (0.69–1.71) 0.736 1.13 (0.67–1.92) 0.642 1.56 (1.03–2.39) 0.038 1.36 (0.99–1.89) 0.062 
Model 3
3
 1.43 (1.11–1.83) 0.005 1.08 (0.68–1.70) 0.746 1.13 (0.67–1.92) 0.651 1.56 (1.02–2.38) 0.039 1.36 (0.98–1.89) 0.064 
v. Difficulty remaining abstinent (n=2,242) 
Model Any MHC Depressive episode Phobia Generalised anxiety disorder Mixed anxiety/depression 
OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p 
Model 1 (unadjusted) 1.88 (1.51–2.34) <0.001 2.58 (1.60–4.17) <0.001 2.03 (1.19–3.47) 0.009 2.36 (1.62–3.45) <0.001 1.38 (1.04–1.83) 0.025 
Model 2
2
 1.74 (1.38–2.20) <0.001 2.47 (1.53–4.01) <0.001 1.67 (0.95–2.94) 0.075 2.05 (1.37–3.06) <0.001 1.30 (0.96–1.77) 0.090 
Model 3 1.65 (1.30–2.10) <0.001 2.55 (1.56–4.15) <0.001 1.60 (0.86–2.98) 0.138 2.01 (1.39–3.17) <0.001 1.21 (0.88–1.66) 0.245 
vi. 12-month quit ratio (ever-smokers in last 12 months, n=3,789) 
Model Any MHC Depressive episode Phobia Generalised anxiety disorder Mixed anxiety/depression 
OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p 
Model 1 (unadjusted) 0.66 (0.46–0.95) 0.027 0.71 (0.33–1.55) 0.392 1.28 (0.56–2.88) 0.558 0.57 (0.29–1.15) 0.119 0.71 (0.43–1.17) 0.182 
Model 2
2
 0.64 (0.43–0.94) 0.022 0.77 (0.36–1.67) 0.512 1.34 (0.61–2.94) 0.468 0.58 (0.29–1.18) 0.133 0.66 (0.39–1.11) 0.119 
Model 3 0.82 (0.55–1.22) 0.317 1.14 (0.51–2.53) 0.746 1.61 (0.72–3.59) 0.242 0.71 (0.35–1.45) 0.350 0.81 (0.47–1.40) 0.451 
1
Including depressive episode phobia, generalised anxiety disorder, obsessive compulsive disorder, panic disorder and mixed anx iety and depressive disorder. 
2
Adjusted for gender (binary: male or female), current 
age (categorical: <25, 25–34, 35–44, 45–54 or 55–64), ethnicity (binary: white or other), partnership status (categori cal: married, single, separated, divorced or widowed), housing tenancy tenure (categorical: 
outright ownership, ownership with outstanding mortgage, or rented/other), occupational position (binary: Registrar-General's classification manual or non-manual occupation), level of education (categori cal: 
degree-level, higher vocational (i.e. HND, teaching), A-level, GCSE or equivalent, or no qualifications) and age when first started smoking (categorical: never smoked regularly, <10, 10–14, 15–19, 20–24 or >25). 
3
Adjusted for all  covariates included in Model 2 in addition to heavy smoking (binary: <20 or ≥20 cigarettes/weekday). 
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Figure 1. Proportions of smokers (solid line), ex-smokers (dashed line) and never-smokers (dotted 
line) in the British population aged 16–64 years overall and according to presence of mental health 
conditions (1993–2014) 
 
Graph 1: Overall British population 
 
Graph 2: Individuals with a CIS-R common mental health condition 
 
Graph 3: Individuals without a CIS-R common mental health condition 
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Footnotes 
1. Until 2016, the ONS Annual Population Survey defined ex-smokers as those who responded “yes” 
to the question “have you ever smoked a cigarette, cigar or pipe?” and “no” to the question “do you 
smoke cigarettes at all nowadays?” It was determined that this method overestimated the 
prevalence of ex-smokers as it includes respondents who had perhaps only smoked just one 
cigarette previously in their life. In response to this, the questions have been changed to “have you 
ever smoked cigarettes regularly?” and “do you smoke cigarettes at all nowadays?”. This has 
reduced the proportion of the population considered to be “ex-smokers” and also consequently 
increased the “never smoked” category (ONS, 2017). 
 
2. Only data from the 2000 wave of APMS were employed in the statistical analysis as information 
on smoking cessation outcomes was only available in 1993 and 2000 and not in subsequent waves. 
 
3. Respondents were defined as having a desire to quit smoking if they had answered “yes” to the 
question “would you like to give up smoking altogether?” in the 2000 wave of APMS. 
 
4. Respondents were defined as perceiving remaining abstinent from smoking for one day to be 
difficult if they had answered “fairly difficult” or “difficult” to the question “how easy or difficult 
would you find it to go without smoking for a whole day?” in the 2000 wave of APMS. 
 
5. Smoking cessation outcomes were measured among all respondents who were regular smokers at 
any time within the past 12 months. Respondents were defined as having successfully quit in the last 
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12 months if they answered “yes” to the questions “have you ever smoked a cigarette?” and “did 
you smoke cigarettes regularly, that is at least one cigarette a day?”, “no” to the question “do you 
smoke cigarettes at all nowadays?”, and “6 months but less than a year ago” or “less than 6 months 
ago” to the question “how long ago did you stop smoking cigarettes regularly?”  Respondents who 
had quit one year ago or more were excluded from the analysis of cessation outcomes.  
 
6. Time to first cigarette after waking was only available for current smokers. Models adjusted for 
heavy smoking, which was available for both current and ex-smokers, instead of HSI score as the 
latter was not available for respondents with successful 12-month cessation outcomes. 
 
7. Of the 7,306 respondents in the 2000 wave of APMS with data on smoking status and MHCs, 
1,371 (18.8%) had any MHC, 237 (3.2%) had depression, 167 (2.3%) had phobia, 395 (5.4%) had GAD, 
64 (0.9%) had panic disorder, 110 (1.5%) had OCD and 692 (9.5%) had mixed anxiety and depression. 
Highlights 
 
 First population-level study of smoking, quitting and mental health within the UK. 
 From 1993 to 2014, smoking prevalence fell in those with and without a condition. 
 Prevalence remained >50% higher among those with a mental health condition. 
 Those with conditions were more likely to smoke but had higher desire to quit.  
 Their lower odds of cessation diminished after adjustment for heavy smoking. 
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